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Abstract
Background—Hepatosteatosis is associated with increased expression of tumor necrosis factor
alpha (TNFα) and interleukin (IL)-12, major T helper (Th) 1 cytokines, and reduced hepatic NKT
cell numbers. The relationship between lipid accumulation, cytokine expression, and hepatic NKT
cells is not known. This study was conducted to assess the role of IL-12 in the development of
hepatic steatosis and its potential impact on liver NKT cells.
Methods—Male C57Bl/6 wild type (Wt) and IL-12-deficient (IL12−/−) mice were fed a choline
deficient diet (CDD) for 0, 10 or 20 weeks.
Findings—CDD led to marked hepatosteatosis, reduced hepatic but not splenic NKT cell
numbers and function and increased hepatic expression of the Th1-type cytokines IL-12, interferon
gamma (IFNγ) and TNFα in wt mice. Absence of IL-12 resulted in similar CDD-induced
hepatosteatosis, but preserved hepatic NKT cells and significantly reduced hepatic IFNγ and
TNFα expression. Treatment of CDD fed mice with lipopolysaccharide led to a significant
increase in hepatic IL12 expression and Kupffer cell (KC)_depletion reduced liver IL-12
expression and restored NKT cells in CDD-induced fatty liver. Interestingly, KCs from CDD fed
mice failed to produce increased quantities of IL12 upon activation in vitro when compared to
similarly treated KCs from control fed mice suggesting that secondary factors in vivo promote
heightened IL-12 production. Finally, human livers with severe steatosis showed a substantial
decrease in NKT and NK cells.
Conclusions—Hepatosteatosis reduces the numbers of hepatic NKT cells in a KC and IL-12-
dependent manner. Our results suggest a pivotal and multi-functional role of KC-derived IL-12 in
the altered immune response in steatotic liver, a process which is likely active within human non-
alcoholic fatty liver disease.
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Introduction
Over the last decade, the role of the liver as a major organ of the innate immune system with
immunomodulatory functions has been increasingly recognized. The liver contains one of
the largest populations of resident macrophages (Kupffer cells [KCs]), natural killer (NK)
cells and natural killer T (NKT) cells 1. They all are important mediators in the innate
immune system, though NKT cells with phenotypic markers of both NK cells and T cells
could represent a link between innate and adaptive immunity 2. NKT cells have attracted a
great deal of attention during the last years, given their role in a variety of immunological
responses including cancer, microbial infection and autoimmunity 3-5. Most NKT cells
recognize lipid antigens presented by the atypical major histocompatibility complex (MHC)
class I-like molecule CD1d, expressed primarily on antigen-presenting cells including
monocytes, macrophages, dendritic cells and B-cells 2, 6. Importantly, the functional
properties attributed to NKT cells appear to be largely due to CD1d-restricted T cells 7. In
addition, NKT cells are either CD4+ or CD4−CD8−, in contrast to typical CD8+ Class I
restricted T cells. Most notably, NKT cells express an extremely limited T cell receptor
repertoire, as their TCR is composed almost exclusively of Vα14/Jα281 paired with Vα8,
Vα7, or Vα2 8, 9, that bind lipids, glycolipids, or highly hydrophobic peptides presented by
CD1d molecules 6, 10. CD1d-restricted T cells demonstrate potent production of both T-
helper (Th)-1 associated cytokines like Interleukin (IL)-12 and Interferon (IFN) γ, and Th2
associated cytokines like IL-4 and IL-10 11 and, therefore, are suitable to affect/control the
local environment in an either pro-inflammatory or anti-inflammatory manner.
Previously, we reported that hepatosteatosis induced by feeding choline deficient diet
(CDD) for 6 weeks_was associated with a substantial reduction in resident NKT cell
numbers, concomitant with increased Th1 cytokine production (i.e. tumor necrosis factor
(TNF)-α, IL-12 and IFNγ) but unchanged levels of Th2 cytokines (i.e. IL-4 and IL-10) 12.
Similar observations have been made in different models of obesity. Leptin-deficient ob/ob
mice 13, insulin-resistant fa/fa Zucker rats 14 and diet-induced obesity 12, 15 in rodents
have shown that hepatosteatosis is associated with changes in local cytokine patterns,
resembling a state of chronic hepatic inflammation with changes in hepatic lymphocyte
subpopulations 12, 15, 16. Together these results suggest that the presence of fat in the liver
alters the hepatic immune system, which likely contributes to their increased susceptibility
to secondary insults. We recently showed that the predominance of Th1 cytokines was even
more pronounced after T cell activation in steatotic liver, associated with elevated signal
transducer and activator of transcription (STAT) 4 and T-box transcription factor expressed
in T cells (T-bet), crucial transcription factors for Th1 commitment 12.
IL-12 was initially termed natural killer cell stimulatory factor because of its ability to
stimulate NK cells 17, but it also was found to stimulate T-regulatory cells and T cells 18.
IL-12 plays an essential role in the protective immune responses against intracellular
pathogens by directing the development of Th1 reactions 19, 20. Different studies suggest a
significant involvement of IL-12 in the process of hepatosteatosis as it influences the local
Th1/Th2 balance and NKT cell activation and regulation, but the exact role of IL-12 in diet-
induced pathogenesis of hepatosteatosis has not been explored 21, 22.
The aim of the present study was to evaluate the role of IL-12 in hepatosteatosis and its
impact on hepatic resident NKT cells and further to determine whether humans suffering
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from hepatosteatosis show a similar reduction in hepatic NKT cells. To this end, using a
choline-deficient diet (CDD) model of hepatosteatosis, we have identified the importance of
IL-12 production by Kupffer cells in the reduction of hepatic NKT cells and translated this
observation of reduced NKT cell numbers to human liver samples with hepatosteatosis.
Materials and Methods
Animals and Treatment
All animals received humane care according to the criteria outlined in the “Guide for the
Care and Use of Laboratory Animals”. The conduct of the study was approved by the
University Institutional Animal Care and Use Committee. Male wild-type (wt) C57BL/6
mice and IL-12 p40-deficient mice were obtained from the Jackson Laboratories (Bar
Harbor, ME). Mice received a choline-deficient-diet (CDD; Dyets, Bethlehem, PA) for 0, 10
or 20 weeks which results in hepatocellular lipid accumulation. For lipopolysaccharide
(LPS) studies, wild type mice fed CDD for 0 or 20 weeks were administered LPS (from
E.coli, Sigma, St. Louis MO) at a concentration of 2.5mg/kg (or saline vehicle) by
intraperitoneal injection 6 hours prior to sacrifice. For NKT cell activation, wt mice fed
CDD for 0 or 10 weeks were administered alpha-galactosylceramide (αGal, Alexis
Chemicals, Axxora, San Diego, CA) at a concentration of 200ng/g by intravenous injection
3 hours prior to sacrifice. All animals were housed in pathogen-free barrier facilities
accredited by the Association for Assessment and Accreditation of Laboratory Animal Care.
All animals had free access to food and water. After 0, 10 or 20 weeks of feeding mice were
sacrificed, serum and tissue collected, and samples stored at −80°C until used.
Depletion and detection of macrophages
Multilamellar liposomes containing clodronate (a gift obtained from Roche Diagnostics
GmbH, Mannheim, Germany) were prepared as described 24. Mice were inoculated
intravenously with 100 μ l of 0.5 mg/ml liposome encapsulated clodronate or PBS as control
suspended in saline. Mice, after 10 weeks on CDD, received clodronate liposomes (or PBS
liposomes as control) for the following 3 weeks; mice after 20 weeks on CDD received
clodronate liposomes (or PBS liposomes as control) for the following 5 weeks every 4-5
days. During clodronate administration, mice were fed CDD continuously. Macrophages
were stained immunohistochemically with F4/80 as previously described 23. Positive cells
were counted from 10 high powered fields from each animal.
KC isolation and in vitro activation
KCs were enriched from livers of 10 week CSD or CDD fed mice. The liver was perfused
with collagenase (0.6mg/ml Collagenase D, Roche Applied Sciences, Indianapolis, IN)
followed by filtration through a 70μm nylon filter. Macrophages were enriched by density
gradient centrifugation on Histogenz (0.288g/14ml, Sigma, St. Louis, MO). Cells at the
interface were plated at 1×105 cells/well on a 48 well tissue culture plate in RPMI 1640 plus
10% fetal calf serum and antibiotics. Following 16hrs, the media was changed and cells
treated with either saline or lipopolysaccharide (10μg/ml) for 3 hours. Cells were then
collected, RNA isolated, and IL-12 gene expression analyzed by real time PCR.
Human liver samples and NKT cell staining
Human liver tissue with different degrees of hepatic steatosis was obtained from subjects
undergoing routine diagnostic liver biopsy under a protocol approved by the UNC
Institutional Review Board or the University of Heidelberg Review Board and subjects gave
written informed consent. Samples presenting with fibrosis, cirrhosis, or significant
inflammatory cell infiltrate indicating hepatitis were excluded. Samples were divided into
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three groups, those showing lipid accumulation in less than 5% of hepatocytes (n=5), those
presenting with steatosis in 6-32% of hepatocytes (n=4), and those showing lipid
accumulation in greater than 33% of hepatocytes per field (n=3). For staining, formalin-
fixed, paraffin embedded sections were stained for NKT cells according to a modified
protocol by Harada K et al. 25. In short, rehydrated samples were blocked with 10% goat
serum, incubated with anti-CD57 (1:200, BD) over night at 4°C, followed by anti-mouse
IgG linked to alkaline phosphatase (1:100, 1h, Sigma). Liquid permanent red (DAKO)
stained subsequently CD57 positive cells red. For T-cell staining, slides were incubated over
night at 4°C with mouse-anti CD3 (Novacastra) follwed by anti-mouse IgG HRP (1:200, 1h,
Amersham). For color development by HRP, the TMB Substrate Kit (Vector Labs) was
used, which stained CD3 positive cells blue and for alkaline phosphatase, liquid permanent
red (DAKO) was used which stained CD57+ cells red. Double positive stained cells (purple)
were identified as NKT cells.
Statistics
Data are presented as mean ± SEM. The statistical significance of difference between CDD-
fed mice and control groups was determined by comparison of the mean using the
independent samples t-test. A p value of < 0.05 was selected as the level of significance.
Statistical analyses were performed using SPSS 11.0 software (SPSS Inc., Chicago, IL).
Results
CDD-induced hepatosteatosis reduces hepatic NKT cell number and function
Previous studies have shown reduced numbers of NKT cells in the presence of liver lipid
accumulation 1. To determine if CDD-induced hepatosteatosis could significantly alter
hepatic NKT cell numbers and/or function, wt mice were fed CDD or CSD as control for 10
weeks followed by administration of either αGal or vehicle. As shown in Figure 1a, feeding
wt mice CDD for 10 weeks led to a reduction hepatic NKT cells as assessed by percentages
of TCRβ and NK1.1 double positive cells and by TCRβ and CD1d-tetramer/PBS57, a
reduction which was associated with significantly reduced IL4 production when compared
to αGal-treated CSD controls (Figure 1b). Together, these data confirm the reduction not
only in number but also function of hepatic NKT cells.
CDD-induced hepatosteatosis is associated with a significant increase in hepatic IL-12
Hepatosteatosis is associated with increased Th1 cytokine expression 12, 15. In our previous
study we reported, following 6 weeks of CDD feeding which induces mild hepatic lipid
accumulation, a strong increase in hepatic Th1 (IFNγ, IL12) cytokine production both in
control treated and concanavalin A treated CDD fed mice 12. Here we wished to better
understand the effects of severe steatosis, a setting where hepatic NKT cell numbers and
function are significantly reduced, on hepatic IL12 expression. Hepatic IL-12 mRNA-levels
were significantly elevated following 10wks of CDD feeding compared to 0 week feeding
(1.09 ± 0.17 fold change in control vs. 7.8 ± 1.09 fold change after 10 weeks CDD, p<0.05)
an elevation which was sustained through 20wks of feeding (10.6 ± 2.8 fold change, p<0.05)
(Figure 2a).
Deficiency in IL12 does not affect the progression of CDD-induced hepatosteatosis
To study the potential implications of IL-12 in hepatosteatosis, IL-12-deficient mice were
fed in addition to Wt mice for 0, 10 and 20 weeks with CDD. As shown in Figure 2b,
microvesicular steatosis developed in both wt and IL12−/− mice following 10 weeks of CDD
feeding which progressed in both to macrovesicular lipid accumulation following 20 weeks
of feeding. This increased lipid accumulation occurred in the absence of significant
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hepatocellular injury as measured by serum alanine aminotransferase levels (Figure 2c).
Liver weight to body weigh ratio was increased following 20 weeks of CDD feeding in both
C57Bl/6 and IL-12−/− mice when compared to 0 weeks of feeding, Figure 2C. Finally,
measurement of hepatic triglycerides confirmed the histopathological findings
demonstrating similar levels of hepatic triglycerides after 10 and 20 weeks of CDD feeding
in wt and IL12−/− mice (Figure 2c). Together, it is clear that IL12 does not significantly alter
the progression of hepatosteatosis following long-term feeding of the choline deficient diet.
IL-12 promotes the induction of Th1-associated cytokines in CDD-induced hepatosteatosis
In addition to increased levels of IL-12, other key Th1-associated cytokines like TNFα and
IFNγ are elevated in different models of hepatosteatosis, whereas Th2-associated cytokines
are not affected 12, 15. Chronic CDD resulted in a significant increase in TNFα and IFNγ
mRNA in Wt mice following 10 or 20 weeks of feeding, where only mild changes were
observed in IL-4 or IL-10 expression. Surprisingly, the absence of IL-12 abrogated the
steatosis-induced increases in Th1-associated cytokines, although mice deficient in IL-12
present with a comparable amount of hepatic fat accumulation (Figure 3).
IL-12 is involved in CDD-induced hepatic NKT cell depletion
In the current study of CDD-induced hepatosteatosis, we observed a severity-dependent
reduction in the hepatic NKT cell population in Wt mice. After 10wks of diet nearly 70%
and after 20wks up to 98% of the resident NKT cell population was depleted (Figure 4a and
b), a finding which was confined to the liver as splenic NKT cell populations were not
affected by CDD feeding (Figure 4c and d). This significant reduction in liver NKT cells
was abrogated in IL-12-deficient mice. After 10wks and 20wks of CDD, no changes in
hepatic NKT cell numbers were observed when compared to 0wk CDD mice (Figure 4).
Together, these results suggest that not IL-12 itself, but a combination of IL-12 in
conjunction with changes in the fatty hepatic microenvironment are likely responsible for
the depletion of hepatic NKT cells.
Hepatic macrophages contribute to IL-12 production
To evaluate the potential source of IL-12 in hepatosteatosis, we investigated the role of
hepatic macrophages in fatty liver. Previous studies reported increased numbers of
macrophages in fatty tissue 26, but the reports concerning fatty liver are inconsistent.
Evaluation of macrophage numbers by immunohistochemistry with F4/80 did not reveal any
increase in their numbers following 10 or 20 weeks of CDD feeding when compared to 0
week CDD mice (Figure 5 A and B). However, steatosis did alter the morphology of the
KCs present with the prominent enlargement in cell size and an elongated, spindled shape.
Consistent with the potential activation of KCs was a significant increase in hepatic CD14
gene expression in wt mice with hepatosteatosis (Figure 5C). To evaluate the influence of
hepatosteatosis on KC function, mice fed a choline deficient diet or control diet for 20
weeks were administered lipopolysaccharide (2.5mg/kg) by intraperitoneal injection. Six
hours following LPS injection, there was a large and significant increase in hepatic IL12
gene expression when compared to LPS-treated CSD-fed mice (Figure 5D). This increase in
IL12 correlated with significantly increased serum aspartate aminotransferase levels in CDD
fed but not CSD fed mice, injury which occurred independent of IL12 (Figure 5E).
Interestingly, in vitro analysis of hepatic macrophage function did not reveal a significant
increase in IL12 expression 3 hours following LPS stimulation in KCs from CDD fed mice
when compared to CSD fed hepatic macrophages (Figure 5F) suggesting that secondary
factors present within the steatotic liver prime macrophages for cytokine release. In sum,
these data demonstrate the enhanced responsiveness of hepatic macrophages to endotoxin
within the steatotic liver, a process which likely involves multiple factors for their
activation.
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KCs contribute to NKT cell loss within the steatotic liver
In order to study the functional role of macrophages in hepatosteatosis and specifically their
impact on resident NKT cells numbers, mice with established fatty liver received clodronate
by intravenous injection according to the time-table presented in Figure 6A. Clodronate is
engulfed selectively by macrophages and induces apoptosis. The control group with fatty
liver received saline (Figure 6B), whereas macrophage depletion was achieved effectively
by clodronate treatment. The absence of macrophages after clodronate treatment was
confirmed using immunohistochemistry (Figure 6B) and did not result in any changes in
liver injury at either the 13 or 25 week time-point when compared to PBS encapsulated
liposome treated CDD fed controls (data not shown) though loss of macrophages did show a
trend toward a reduction in hepatic lipid accumulation (32.40±8.17 vs. 17.89±4.62 for CDD-
fed mice treated with PBS liposomes vs. CDD-fed mice treated with clodronate
encapsulated liposomes, p=0.104).
KCs play a major role in innate immunity and are a likely source for IL-12 in the liver 27.
Therefore, we measured hepatic IL-12 and IFNγ expression as well as IL-4 and IL-10 gene
expression using real-time PCR after clodronate (or vehicle) treatment in Wt mice (Figure
6C). KC depletion blunted steatosis-induced hepatic IL-12 and IFNγ gene expression and
had no effect on Th2-associated cytokines. In addition, KC depletion led to a complete
repopulation of hepatic NKT cells following 10 weeks of CDD (Figure 7). Even after 20
weeks of CDD with an almost complete loss of NKT cells in hepatosteatosis, 5 weeks of
clodronate-treatment was sufficient to restore NKT cells. To eliminate possible non-specific
effects of clodronate treatment, IL12–deficient mice fed CDD for 10 weeks were
administered clodronate for 3 weeks. Hepatic NKT cell populations were not changed from
untreated CDD fed mice (data not shown). These results suggest that KCs, either directly or
indirectly, contribute to the production of IL-12 and continually deplete hepatic NKT cells
within the steatotic liver.
NKT cell populations are reduced in human non-alcoholic hepatosteatosis
Recently, reduced peripheral NKT cell numbers in the blood of patients suffering from non
alcoholic fatty liver disease have been reported 28, but no data exist regarding NKT-cell
numbers in human steatotic livers. Human liver samples were obtained from the Liver
Diseases Unit at the University of North Carolina and from the Department of Pathology at
the University of Heidelberg from patients with different degrees of hepatosteatosis.
Samples were selected based on the absence of severe inflammation, fibrosis or cirrhosis, to
more clearly evaluate the influence of steatosis alone on hepatic NKT cells. As shown in
Figure 8, liver sections from patients with steatosis present in 6-32% of hepatocytes had
reduced numbers of NKT cells. With severe steatosis, hepatic NKT cells are even further
reduced when compared to healthy control livers. Together, these data suggest that, as is
seen in the rodent model of hepatosteatosis, non-alcoholic hepatosteatosis in humans results
in a decrease in the numbers of hepatic NKT cells.
Discussion
NKT cells represent a population of highly specialized lymphocytes involved in regulation
of the immune system. As NKT are 20-25% of hepatic mononuclear cells and share features
of both classical T cells and natural killer (NK) cells, they represent an important link
between innate and adaptive immunity through production of both Th1 and Th2 associated
cytokines 2. Findings from the current study confirm the ability of hepatocellular lipid
accumulation to decrease the numbers and function of this important resident lymphocyte
population both in mice and humans and experimentally define an IL-12 and KC-associated
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mechanism for their depletion. Together, these studies provide new and important
information regarding the impact of hepatosteatosis on resident NKT cells.
Previous studies in fatty livers of obese, leptin-deficient ob/ob mice reported reduced NKT
cell numbers within the liver 16, and this reduction was confirmed in a number of different
models of diet-induced hepatosteatosis 12, 14, 15. Interestingly, either adoptive transfer of
wild type NKT cells or activation of NKT cells with the naturally occurring glycolipid
glucocerebroside in leptin deficient ob/ob mice led to changes in hepatic lipid content,
specifically a movement from macrovesicular to microvesicular fat, and improvement in
glucose tolerance suggesting that NKT cells may be inhibitors of hepatosteatosis 29, 30.
However, our findings suggest that in CDD-induced hepatosteatosis, the restoration of NKT
cells and suppression of Th1 cytokine response in IL12−/− mice is insufficient to affect
hepatic triglyceride accumulation. The reasons for the lack of effect on lipid accumulation is
not known with certainty. It is clear that other inflammatory cytokines, TNFα in particular,
are capable of promoting non-alcoholic 31 and alcoholic steatosis 32 and studies from our
own lab would suggest that TNFα is active and important for lipid accumulation in this
model (unpublished observation). In the absence of IL12, TNFα levels are reduced to at or
near control levels. It could be that their presence, even if at a very minimal level, is capable
of promoting and sustaining lipid accumulation. Further study is required to better
understand the critical factors for steatosis development. Nevertheless, the current study
demonstrates the inability of IL12 alone to promote lipid accumulation. In sum, as the
severity-dependent reduction of hepatic NKT cell numbers is restricted to the liver and
peripheral NKT cells in spleen are not affected, the local hepatic environment seems to
effectuate the loss of resident NKT cell numbers, a process which involves IL-12
production.
Over the time course of 20 weeks, CDD results in severe hepatosteatosis with absence of
inflammation or necrosis. It is associated with a significant increase in hepatic IL-12
expression. IL-12 is known to stimulate NKT and other immune-competent T cells and NK
cells to release IFNγ 33, but conflicting data exists concerning their viability after IL-12
exposure. Whereas Ito et al. 34, 35 found increased numbers of hepatic NKT cells after
IL-12 stimulation, Takahashi et al. report the ability of IL-12 to reduce NKT cell-viability
36, and Matsui et al. also observed a reduction in NKT cell numbers by IL-12 through
activation-induced cell death 37. In the current study, we demonstrate a significant increase
in hepatic IL-12 expression and an IL-12-dependent loss of hepatic NKT cells within the
steatotic liver. It is likely that multiple factors present within the steatotic liver sensitize
NKT cells specifically to IL-12-associated depletion. Alternatively, IL12 could operate
through other cytokines or factors as IL12-deficient mice show significant reductions in the
expression of TNFα and IFNγ and the function of these mediators on NKT cell function has
not been elucidated. In as much as IL12 promotes loss of NKT cells, it may also provide a
supportive signal for hepatic NK cells. Originally described as an NK cell inducing factor
18, IL12 likely supports NK cell recruitment and or survival though the net effect this has on
NKT cell function or hepatosteatosis development remains to be determined. Together,
however, findings from the current study strongly implicate IL-12 as a key factor in the
depletion of this important immunomodulatory cell population within the murine steatotic
liver.
In addition to demonstrating the importance of IL-12 in the depletion of NKT cells from the
steatotic liver, the current study has further investigated the potential source of IL-12
implicating KCs in this production. Upon activation by endotoxin, resident hepatic
macrophages produce pro-inflammatory mediators including TNFα and IL-12 13, 38. In
alcoholic liver disease, these mediators are associated with the promotion of liver injury and
hepatocyte lipid accumulation 32. The impact of non-alcoholic steatosis on KC activation is
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not well understood. In leptin deficient mice which present with a fatty liver, hepatic
macrophage cytokine production, including IL-12 production, is increased 13. Findings from
the current study would further suggest that steatosis alone may induce significant KC
activation. Using hepatic CD14 gene expression within the steatotic liver as an indirect
measure of macrophage activation, we provide data showing a correlation between the
severity of hepatosteatosis and the level of CD14 expression independent of alterations in
hepatic macrophage numbers. In addition, upon stimulation with LPS in vivo, steatotic livers
express significantly greater quantities of IL12 and show significantly enhanced
hepatocellular injury though this injury occurs independently of IL-12 induction.
Interestingly, KCs isolated from CDD fed wt mice did not express increased levels of IL12
either basally or when activated by LPS in vitro compared to comparably treated CSD fed
wt mouse KCs suggesting that secondary factors present within the steatotic liver promote
IL-12 production in the presence of LPS. Alternatively, KC-associated IL12 is not the only
source of this important, NKT cell depleting cytokine. Previous studies in ischemia and
reperfusion models have demonstrated the ability of hepatocytes to produce IL12 39. In the
in vivo setting, changes in fat metabolism with unusually high levels of metabolites,
increased oxidative stress with consequent lipid peroxidation could promote heightened KC
responsiveness 40, 41 and the release of pro-inflammatory cytokines like TNFα or IL-12 by
hepatocytes and lymphocytes 15, 42. Likewise, the potential impact of KCs on the
development of hepatosteatosis in this model remains to be determined. It is clear that unlike
loss of IL12, loss of hepatic macrophages leads to a substantial, though not significant,
reduction in hepatic lipid accumulation following 10 and 20 weeks of CDD feeding
indicating that other factors produced by KCs could potentially be important for hepatic
lipid accumulation. Further study will be required to concretely identify these factors in the
setting of severe hepatosteatosis. Data presented here do however implicate hepatic
macrophages either directly or indirectly in the production of IL-12 as depletion of these
cells reduced hepatic IL-12 expression, balanced the Th cytokine profile of the liver, and led
to a reconstitution of NKT cells within the livers of mice with established hepatosteatosis.
Together, these data provide additional new insights into the complexities and potential
sources of IL-12 production within the steatotic liver.
Hepatosteatosis results in a shifted, Th1 predominated, cytokine response 12. The reasons
for this shift likely involve increased oxidant production, reduced oxidant defense capacity,
and/or modulation of intrahepatic immune cell populations or function. Data from the
current study implicate IL-12 and/or loss of NKT cells in the promotion of a Th1-shifted
response. IL-12 is known to induce T cells to produce large amounts of IFNγ and activate
Th1 transcription factors including signal transducer and activator of transcription (STAT) 4
20. NKT cells may also balance the local cytokine response within the liver. Li and others
reported an increased susceptibility of leptin deficient ob/ob mice to endotoxin-induced liver
damage with an increase in the hepatic production of Th1 cytokines including IFNγ, a
known mediator of endotoxin-induced liver damage 1. Loss of IL-12 reduced hepatic IFNγ
expression in the current study, but also preserved the hepatic NKT cell populations, making
it difficult to determine which of these are responsible for the disrupted Th balance in the
steatotic liver. Nevertheless, findings from the current study demonstrate the importance of
IL12 in the depletion of hepatic NKT cells in the setting of severe steatosis, a process which
is associated with restoration of a balanced hepatic Th cytokine profile.
Utilizing biopsies from patients with mild to severe hepatosteatosis, we present intriguing
evidence to suggest a similar correlation between the degree of steatosis and the numbers of
hepatic NKT cells present in humans where NKT cell numbers decreased when
hepatosteatosis was moderate to severe. Due to small sample size, it was not possible to
determine if IL-12 was up-regulated in these samples as was observed experimentally
though previous investigations have demonstrated increased pro-inflammatory cytokines
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within the human steatotic liver 43. Nevertheless, the findings presented here provide the
first line of evidence in humans to suggest that hepatosteatosis may indeed be a key
modulator of hepatic lymphocyte populations.
In summary, these results demonstrate a connection between hepatosteatosis-induced IL-12
production and the loss of resident NKT cells and implicate NKT cells in the suppression of
Th1-type cytokine production within the steatotic liver. Moreover, we provide evidence for
the first time that suggests a similar connection between fatty liver and loss hepatic NKT
cells in humans. Several questions remain including the nature of the stimulus responsible
for increasing KC-associated IL-12 expression and the clear mechanism for how IL-12
mediates its effects on hepatic NKT cell populations. Also, it is of great interest what other
effects a loss of NKT cells might have on the steatotic liver. It is well appreciated that both
NKT cells and NK cells play a significant role in tumor cell surveillance and clearance and
that disruption of NKT and/or NK cell function may predispose the liver to secondary
pathologies including carcinogenesis. In conclusion, the current study provides important
new mechanistic information regarding NKT cell depletion within the steatotic liver and
identifies potential new therapeutic targets to preserve this critical resident immune cell
population of the liver.
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Abbreviations
αGal (alpha galactosylceramide)
CDD (choline deficient diet)
CSD (choline sufficient diet)
DAB (diaminobenzidine)
ECL (enhanced chemiluminescence)
ELISA (enzyme linked immunosorbent assay)
H&E (hematoxylin and eosin)





MHC (major histocompatability complex)
M-MLV (murine moloney virus)
NK (natural killer)
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NKT (natural killer T)
PBS (phosphate buffered saline)
PCR (polymerase chain reaction)
PE (phycoerythrin)
RT (reverse transcription)
SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis)
SEM (standard error of the mean)
STAT (signal transducer and activator of transcription)
T-bet (t box transcription factor expressed in T cells)
TCR (t cell receptor)
Th (T helper)
TMB (tetramethylbenzidine)
TNFα (tumor necrosis factor alpha)
T-TBS (tween-20 tris buffered saline)
Wt (wild type)
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Figure 1. Hepatic NKT cell number and function are reduced within the steatotic liver
A. Hepatic mononuclear cells were analyzed by flow cytometry for T cell receptor beta
(TCRβ ) and NK1.1 expression or TCRβ and binding to CD1d-tetramer loaded with PBS57
in mice fed choline sufficient diet (CSD) or choline deficient diet (CDD) for 10 weeks.
Representative dot plots presented. B. Hepatic IL4 protein expression was measured by
ELISA 3 hours following i.v. alpha galactosylceramide (αGal, 200ng/g) administration to
10 week CSD fed or CDD fed mice. n= 6-9 mice per group. *p<0.05 vs. CSD fed vehicle
treated mice, +p<0.05 vs. CSD fed, αGal treated mice.
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Figure 2. Increased IL12 production does not influence the progression of hepatosteatosis
following long-term CDD feeding
A. C57BL/6 mice were fed CDD for 0, 10 or 20 weeks. Hepatic IL-12 expression was
determined by quantitative real time PCR of whole liver tissue while serum IL-12 was
measured by ELISA. Values are means ± SEM,. B. H&E stained liver histology after 0, 10
and 20 weeks of CDD in C57BL/6 (Wt) and IL-12−/− mice. Representative
photomicrographs are presented at 100x magnification with 400x inserts (bottom right of
each image). C. Serum alanine aminotransferase, liver weight to body weight ratio (LW/
BW) and hepatic triglycerides were measured following either 0, 10 or 20 weeks of CDD
feeding. No significant differences were observed between Wt and IL-12−/− mice in any of
these parameters. Values are means ± SEM, *p<0.05, n=4-8 animals per group.
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Figure 3. IL-12 promotes Th1 cytokine expression within the steatotic liver
Hepatic Th1 (TNFα and IFNγ) and Th2 (IL-4 or IL-10) cytokine gene expression was
measured by real time PCR in wt and IL12−/− mice fed CDD for 0, 10 or 20 weeks. Values
are means ± SEM, *p<0.05; n = 4-8 animals per group.
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Figure 4. IL-12 is involved in steatosis-associated hepatic NKT cell depletion
C57BL/6 (Wt) and Interleukin (IL)-12−/− mice were fed CDD for 0, 10 or 20 weeks and
total liver mononuclear cells were analyzed by flow cytometry. Hepatic mononuclear cells
(A) or splenocytes (C) were stained with anti-mouse T cell receptor β (TCR) and natural
killer (NK) 1.1 antibodies. T cells, NKT cells and NK cells are outlined in boxes. Values
represent percent of total liver mononuclear cells analyzed. B and D. Quantitation of hepatic
(B) or splenic (D) NKT cells expressed as percent of total hepatic CD3+ cells expressing
NK1.1. Figure is representative for 3-6 different experiments. Results are representative of
3-6 animals per group.
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Figure 5. Kupffer cells are activated within the steatotic liver
A. Liver sections from wild type mice fed CDD for 0, 10 or 20 weeks were stained with
F4/80. Representative 400x photomicrographs presented. B. Quantitation of F4/80 positive
cells per 400x field. Ten fields per section from each mouse were analyzed. C. Hepatic
CD14 gene expression was measured using real time PCR. D. Hepatic IL12 gene expression
6 hours following LPS injection. E. Serum aspartate aminotransferase levels 6 hours
following lipopolysaccharide (LPS, 2.5mg/kg) injection in wt or IL12−/− mice fed choline
sufficient diet (CSD) or CDD diet for 20 weeks. F. IL12 expression 3 hours following
treatment with either saline or LPS (10μg/ml) in isolated hepatic macrophage (Mφ) from wt
mice fed either a choline sufficient diet or choline deficient diet for 10 weeks.
Representative data from two independent experiments shown. Values are mean ± SEM,
*p<0.05 versus respective control, +p<0.05 versus LPS-treated choline sufficient diet fed
mice; n = 4-8 animals per group.
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Figure 6. Clodronate depletes Kupffer cells and ameliorates increased Th1 associated cytokine
expression in steatotic liver tissue
A. Dosing regimen for macrophage depletion studies. Mice with established hepatosteatosis
after 10 weeks of CDD were injected every 4-5 days with clodronate for the following 3
weeks, mice after 20 weeks of CDD received clodronate every 4-5 days for the following 5
weeks while continuously fed CDD. B. Liver sections stained with F4/80 antibody from wt
mice administered vehicle or clodronate as described in A. Representative photomicrographs
at 400x magnification presented. C. Hepatic Th1 and Th2 cytokine expression as assessed by
real-time PCR in vehicle or clodronate treated animals. Values are mean ± SEM, *p<0.05.
n=4-6 animals per group.
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Figure 7. Kupffer cells contribute to steatotosis-induced hepatic NKT cell depletion
Hepatic mononuclear cells were isolated from vehicle or clodronate treated wild type mice
fed choline deficient diet for indicated time periods and subpopulations of lymphocytes
assessed by flow cytometry. Results are representative of 4-6 different experiments, p<0.01.
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Figure 8. Hepatosteatosis is associated with decreased numbers of NKT and NK cells in humans
Human liver biopsies were divided into three groups as described in methods. Slides were
stained for CD3 and CD57, a marker for human NK cells. CD3 positive cells stained blue,
NK positive cells present red. Double positive cells are termed NKT cells. A. Representative
microphotographs of stained tissue are presented, NKT cells are pointed out by arrows. B.
Quantitation of NKT cells were counted from at least 10 400x pictures of the tissue.
Representative results for n = 3-5 per group. Values are means ± SEM.
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